Northern Trust Corp Exelixis, Inc. Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 2,370,922 shares of EXEL stock, worth $102 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,370,922
Previous 2,478,460 4.34%
Holding current value
$102 Million
Previous $82.5 Million 6.06%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$32.38 - $39.16 $3.48 Million - $4.21 Million
-107,538 Reduced 4.34%
2,370,922 $87.5 Million
Q4 2024

Feb 14, 2025
BUY
$25.39 - $36.46 $12.9 Million - $18.5 Million
506,539 Added 25.69%
2,478,460 $82.5 Million
Q3 2024

Nov 13, 2024
SELL
$21.96 - $27.6 $2.65 Million - $3.33 Million
-120,493 Reduced 5.76%
1,971,921 $51.2 Million
Q2 2024

Aug 14, 2024
BUY
$20.34 - $23.73 $3.94 Million - $4.59 Million
193,472 Added 10.19%
2,092,414 $47 Million
Q1 2024

May 14, 2024
SELL
$20.17 - $23.93 $6.45 Million - $7.65 Million
-319,891 Reduced 14.42%
1,898,942 $45.1 Million
Q4 2023

Feb 13, 2024
SELL
$19.25 - $24.13 $972,914 - $1.22 Million
-50,541 Reduced 2.23%
2,218,833 $53.2 Million
Q3 2023

Nov 13, 2023
SELL
$19.04 - $22.74 $1.04 Million - $1.24 Million
-54,532 Reduced 2.35%
2,269,374 $49.6 Million
Q2 2023

Aug 11, 2023
SELL
$18.17 - $20.48 $2.91 Million - $3.28 Million
-160,328 Reduced 6.45%
2,323,906 $44.4 Million
Q1 2023

May 15, 2023
BUY
$16.3 - $19.41 $790,012 - $940,744
48,467 Added 1.99%
2,484,234 $48.2 Million
Q4 2022

Feb 13, 2023
BUY
$14.96 - $17.39 $150,258 - $174,665
10,044 Added 0.41%
2,435,767 $39.1 Million
Q3 2022

Nov 14, 2022
SELL
$15.68 - $22.27 $273,286 - $388,143
-17,429 Reduced 0.71%
2,425,723 $38 Million
Q2 2022

Aug 12, 2022
SELL
$17.44 - $23.16 $508,655 - $675,484
-29,166 Reduced 1.18%
2,443,152 $50.9 Million
Q1 2022

May 13, 2022
SELL
$17.03 - $22.67 $956,966 - $1.27 Million
-56,193 Reduced 2.22%
2,472,318 $56 Million
Q4 2021

Feb 08, 2022
SELL
$15.84 - $21.88 $612,421 - $845,946
-38,663 Reduced 1.51%
2,528,511 $46.2 Million
Q3 2021

Nov 15, 2021
SELL
$16.3 - $21.14 $578,487 - $750,258
-35,490 Reduced 1.36%
2,567,174 $54.3 Million
Q2 2021

Aug 13, 2021
SELL
$17.95 - $25.56 $247,799 - $352,855
-13,805 Reduced 0.53%
2,602,664 $47.4 Million
Q1 2021

May 12, 2021
BUY
$20.53 - $25.22 $4.29 Million - $5.27 Million
208,953 Added 8.68%
2,616,469 $59.1 Million
Q4 2020

Feb 11, 2021
SELL
$18.39 - $24.8 $144,582 - $194,977
-7,862 Reduced 0.33%
2,407,516 $48.3 Million
Q3 2020

Nov 16, 2020
SELL
$20.67 - $26.94 $1.67 Million - $2.18 Million
-80,952 Reduced 3.24%
2,415,378 $59.1 Million
Q2 2020

Aug 14, 2020
BUY
$16.46 - $27.42 $715,368 - $1.19 Million
43,461 Added 1.77%
2,496,330 $59.3 Million
Q1 2020

May 14, 2020
BUY
$14.46 - $21.8 $1.27 Million - $1.91 Million
87,799 Added 3.71%
2,452,869 $42.2 Million
Q4 2019

Feb 14, 2020
BUY
$15.15 - $18.89 $126,744 - $158,033
8,366 Added 0.35%
2,365,070 $41.7 Million
Q3 2019

Nov 13, 2019
SELL
$17.68 - $22.65 $1.28 Million - $1.64 Million
-72,480 Reduced 2.98%
2,356,704 $41.7 Million
Q2 2019

Aug 13, 2019
BUY
$18.93 - $24.75 $549,821 - $718,863
29,045 Added 1.21%
2,429,184 $51.9 Million
Q1 2019

May 13, 2019
BUY
$19.6 - $24.76 $1.91 Million - $2.42 Million
97,649 Added 4.24%
2,400,139 $57.1 Million
Q4 2018

Feb 12, 2019
BUY
$13.65 - $21.8 $568,891 - $908,558
41,677 Added 1.84%
2,302,490 $45.3 Million
Q3 2018

Nov 14, 2018
BUY
$15.87 - $22.4 $12.5 Million - $17.6 Million
785,550 Added 53.25%
2,260,813 $40.1 Million
Q2 2018

Sep 18, 2018
SELL
$18.56 - $22.45 $355,776 - $430,344
-19,169 Reduced 1.28%
1,475,263 $31.7 Million
Q2 2018

Aug 14, 2018
BUY
$18.56 - $22.45 $2.51 Million - $3.04 Million
135,340 Added 9.96%
1,494,432 $32.2 Million
Q1 2018

May 09, 2018
SELL
$22.15 - $31.89 $56,504 - $81,351
-2,551 Reduced 0.19%
1,359,092 $30.1 Million
Q4 2017

Feb 14, 2018
SELL
$24.23 - $30.93 $345,592 - $441,154
-14,263 Reduced 1.04%
1,361,643 $41.4 Million
Q3 2017

Nov 13, 2017
BUY
$23.35 - $29.24 $32.1 Million - $40.2 Million
1,375,906
1,375,906 $33.3 Million

Others Institutions Holding EXEL

# of Institutions
613
Shares Held
257M
Call Options Held
1.57M
Put Options Held
730K
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email